Currently we have five separate active development programs focused in Immunology that will ultimately provide physicians and patients with accurate solutions to massive healthcare problems that will improve outcomes and help eliminate waste.
Blood test detecting mRNA biomarkers highly predictive of TNFi response and non-response across all approved indications.
Blood test detecting mRNA biomarkers to predict TNFi response and non-response in patient with Ulcerative Colitis and Crohn’s Disease.
Blood test detecting mRNA biomarkers to predict TNFi response and non-response in patient with Rheumatoid Arthritis.
Blood test detecting mRNA biomarkers to predict TNFi response and non-response in patient with Psoriasis and Psoriatic Arthritis.
Blood test detecting relevant mRNA biomarkers that will provide an accurate diagnosis and prognosis of Crohn’s disease or Ulcerative Colitis.
Blood test detecting mRNA biomarkers highly predictive of a4-B7 integrin inhibitor response and non-response in patients with Ulcerative Colitis and Crohn’s Disease.